Your browser doesn't support javascript.
loading
Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease.
Atanelishvili, Ilia; Akter, Tanjina; Noguchi, Atsushi; Vuyiv, Olha; Wollin, Lutz; Silver, Richard M; Bogatkevich, Galina S.
Afiliação
  • Atanelishvili I; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Akter T; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Noguchi A; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA; and Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Vuyiv O; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Wollin L; Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.
  • Silver RM; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Bogatkevich GS; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. bogatkev@musc.edu.
Clin Exp Rheumatol ; 37 Suppl 119(4): 115-124, 2019.
Article em En | MEDLINE | ID: mdl-31573469
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Inibidores de Proteínas Quinases / Fibrose Pulmonar Idiopática / Indóis Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Inibidores de Proteínas Quinases / Fibrose Pulmonar Idiopática / Indóis Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article